Additional file 6: Figure S2. of Identification of stromal ColXÎą1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer

20× image of the H&E stained RCB3 case shown in Fig. 3 to highlight the number of tumor cells in this case. (PNG 289 kb)